About Shanghai Shen Lian Biomedical Corporation Company

The company was founded in June 2001. The company is a high-tech enterprise specializing in R&D, production and sales of veterinary biological products. The company always takes R&D innovation as the driving force for enterprise development, insists on independent innovation, and strives to become a leading enterprise in the veterinary biological products industry in China. In October 2019, the company was successfully listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange. The company is a high-tech enterprise specializing in R&D, production and sales of veterinary biological products. Its main business covers R&D, production and sales of veterinary preventive biological products and veterinary diagnostic products. The main products are a series of swine, bovine and sheep foot-and-mouth disease vaccines, porcine circovirus type 2 subunit vaccines, inactivated bovine nodular dermatosis vaccines, and a series of veterinary diagnostic products. Corporate honors: Second prize of the National Science and Technology Progress Award, New Veterinary Drug Registration Certificate, China (Shanghai) International Invention and Innovation Exhibition Gold Award. It won the honorary title of “Caring Unit” by the Gansu Poverty Alleviation Foundation, the 7th China (Shanghai) International Invention and Innovation Exhibition Gold Award, the 6th China (Shanghai) International Invention and Innovation Exhibition Gold Award, the Shanghai Minhang District Trade Secret Protection Demonstration Site, the 33rd Shanghai Outstanding Invention Selection Competition Outstanding Invention Project Gold Award, the 25th National Invention Exhibition Gold Award, the 2009 Shanghai High-tech Achievement Transformation Project Top 10 Independent Innovation Project, and the 2012 Shanghai Private Technology Enterprise R&D Top 100.